Exclusive Interview with Dr. Ibrahim El-Demiaty for "Dawa News"

Foundation and Establishment: A New Vision for the Pharmaceutical Market

Dr. Ibrahim El-Demiaty confirms that the establishment of Brave Pharma came from a strong desire to fill the gaps in the Egyptian pharmaceutical market, whether in terms of the availability of biological products or ensuring their quality according to global standards. He added:

"We have observed a clear shortage of some essential treatments, in addition to the high cost of some imported medicines, which strongly motivated us to establish a pharmaceutical company capable of providing advanced therapeutic solutions of high quality at an affordable cost for patients."

Regarding the supporting investors of the company, he explained that Brave Pharma relies on a group of partners with extensive experience in the pharmaceutical and health investment sectors, along with strategic partnerships with local, regional, and global pharmaceutical manufacturing institutions. He adds:

"What distinguishes this collaboration is our focus on innovation and sustainability, which is reflected in our commitment to our company's motto 'Crown of Health,' which expresses our vision that health is a crown above the heads of the healthy."

Competitive Vision and Market Distinction

What distinguishes "Brave Pharma" from others? The executive director believes that the combination of innovation, quality, and reasonable cost is the key element in the company's distinction. In addition to providing pharmaceutical products of global quality, the company focuses on continuous research and development, and establishing strong partnerships with international entities to ensure the availability of the latest treatments in the Egyptian market.

"We do not just provide medicines; we focus on integrated pharmaceutical solutions that include continuous research and development, and we work to ensure their availability at fair prices without compromising quality."

Regarding the therapeutic categories that Brave Pharma focuses on, he pointed out that the company specializes in medications for treating inflammation and swelling, treating polycystic ovary syndrome and improving fertility, weight loss, diabetes medications, and the nervous system, in addition to treatments for muscle inflammation and fibrous tissues.

New Launches and Innovative Products

In the context of discussing the products that Brave Pharma has launched in the Egyptian market, Dr. El-Demiaty revealed that the company has launched the drug "Enzymorif," which is an effective treatment for all types of inflammation and swelling after surgical operations, and it has received wide acceptance among doctors and pharmacists due to its high efficacy and competitive price.

The company also launched the drug "Chromova," which is an innovative treatment for insulin resistance, playing a key role in treating diabetes, polycystic ovary syndrome, improving fertility, and reducing excess weight.

Regarding expansion plans in 2024, he indicated that the company is preparing to launch new formulations, including a drug to treat peripheral nerve inflammation resulting from diabetes complications, and another drug to treat muscle inflammation and fibrous tissues.

Local and International Expansion: Vision 2025 and Beyond

Is Brave Pharma looking to expand outside Egypt? Dr. El-Demiaty explained that the company is strongly seeking to penetrate regional markets, especially in the Middle East and Africa, where there are tremendous growth opportunities. He added:

"We aim to export some of our products during the coming year, and we have ambitious plans to enhance our presence in Arab and African markets, both in the northern and southern parts of the continent."

On the local level, the company focuses on expanding production operations through cooperation with globally accredited pharmaceutical factories to meet the needs of the Egyptian market and neighboring markets.

Keeping Up with Digital Transformation and Investing in Technology

With the digital developments taking place around the world, Brave Pharma is investing in technology and artificial intelligence to enhance its operations. Dr. El-Demiaty explained that the company plans to develop digital platforms to increase health awareness among patients and explore AI technologies to analyze clinical data, which helps improve the efficiency of the treatments provided.

"We are not just focused on producing medicines; we believe that the future relies on technology. Therefore, we are working to enhance our digital presence to provide smart and innovative pharmaceutical solutions."

Challenges Facing the Pharmaceutical Sector in Egypt and How to Overcome Them

When asked about the challenges facing the pharmaceutical sector in Egypt, Dr. El-Demiaty pointed out that fluctuations in raw material prices and shortages of some essential components are among the biggest obstacles facing pharmaceutical companies.

"We are addressing these challenges by diversifying our supply sources and signing long-term contracts with suppliers to ensure the stability of production operations. We are also working to increase the proportion of local components in drug manufacturing to reduce reliance on imports."

He also emphasized the importance of encouraging local manufacturing and reducing reliance on imports, while enhancing research and development in the pharmaceutical sector.

Brave Pharma's Message to the Health Community and Patients

At the end of the interview, Dr. Ibrahim El-Demiaty directed a message to patients and health sector workers, saying:

"We are committed to providing innovative, high-quality medicines at fair prices, and we are working to develop treatments that meet market needs. Our primary goal is to improve the quality of life for patients and support the healthcare system in Egypt and beyond."

Regarding the company's future vision, he confirmed that it aims to become a leader in the pharmaceutical industry in the region over the coming years, continuing to develop innovative medicines and expanding their export to foreign markets.

"We do not just sell products; we provide integrated pharmaceutical solutions aimed at achieving the best possible healthcare."

Brave Pharma: Innovation and Quality at the Heart of the Pharmaceutical Industry

Thanks to its ambitious strategies in research and development, regional expansion, and investment in technology, Brave Pharma aims to be a key player in the Egyptian and global pharmaceutical markets, presenting a new model in the healthcare sector based on innovation, sustainability, and quality.